Company / Tangible Book Value per Share
Cardiff Oncology, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$0.68
FY2025
5-year range
$0.68 / $3.48
FY2021-FY2025
Trend
-56.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Tangible Book Value per Share has declined for 5 consecutive years, from $14.91 in FY2020 to $0.68 in FY2025.
Based on SEC 10-K filings.
0.68 in FY2025 with a 5-year CAGR of -46.0%.
Declined from $2.38 to $0.68 over the past 2 years.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -41.1%
- 5-Year CAGR
- -46.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- Cardiff Oncology, Inc.'s tangible book value per share has declined for 5 consecutive years.
- In FY2025, tangible book value per share decreased 56.3% year-over-year.
- Peak tangible book value per share was recorded in FY2020.
- Lowest tangible book value per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.68 | -56.3% |
| FY2024 | $1.56 | -34.4% |
| FY2023 | $2.38 | -28.9% |
| FY2022 | $3.35 | -4.0% |
| FY2021 | $3.48 | -76.6% |
| FY2020 | $14.91 | +681.5% |
| FY2019 | $1.91 | -78.5% |
| FY2018 | $8.87 | +1277.9% |
| FY2017 | $0.64 | -60.7% |
| FY2016 | $1.64 | -36.4% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026